Free Trial

H.B. Fuller (FUL) Competitors

H.B. Fuller logo
$75.72 -0.36 (-0.47%)
(As of 11/14/2024 ET)

FUL vs. ALB, CE, BCPC, NEU, ASH, SXT, IOSP, KWR, MTX, and SCL

Should you be buying H.B. Fuller stock or one of its competitors? The main competitors of H.B. Fuller include Albemarle (ALB), Celanese (CE), Balchem (BCPC), NewMarket (NEU), Ashland (ASH), Sensient Technologies (SXT), Innospec (IOSP), Quaker Chemical (KWR), Minerals Technologies (MTX), and Stepan (SCL). These companies are all part of the "specialty chemicals" industry.

H.B. Fuller vs.

Albemarle (NYSE:ALB) and H.B. Fuller (NYSE:FUL) are both basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their risk, media sentiment, valuation, community ranking, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 1.6%. H.B. Fuller pays an annual dividend of $0.89 per share and has a dividend yield of 1.2%. Albemarle pays out -9.7% of its earnings in the form of a dividend. H.B. Fuller pays out 27.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Albemarle has raised its dividend for 30 consecutive years and H.B. Fuller has raised its dividend for 56 consecutive years. Albemarle is clearly the better dividend stock, given its higher yield and lower payout ratio.

Albemarle received 458 more outperform votes than H.B. Fuller when rated by MarketBeat users. Likewise, 62.88% of users gave Albemarle an outperform vote while only 56.03% of users gave H.B. Fuller an outperform vote.

CompanyUnderperformOutperform
AlbemarleOutperform Votes
774
62.88%
Underperform Votes
457
37.12%
H.B. FullerOutperform Votes
316
56.03%
Underperform Votes
248
43.97%

Albemarle has higher revenue and earnings than H.B. Fuller. Albemarle is trading at a lower price-to-earnings ratio than H.B. Fuller, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Albemarle$9.62B1.25$1.57B-$16.75-6.09
H.B. Fuller$3.51B1.18$144.91M$3.2423.37

H.B. Fuller has a net margin of 5.15% compared to Albemarle's net margin of -28.80%. H.B. Fuller's return on equity of 13.39% beat Albemarle's return on equity.

Company Net Margins Return on Equity Return on Assets
Albemarle-28.80% 1.67% 0.84%
H.B. Fuller 5.15%13.39%4.97%

Albemarle has a beta of 1.55, meaning that its share price is 55% more volatile than the S&P 500. Comparatively, H.B. Fuller has a beta of 1.42, meaning that its share price is 42% more volatile than the S&P 500.

In the previous week, Albemarle had 12 more articles in the media than H.B. Fuller. MarketBeat recorded 13 mentions for Albemarle and 1 mentions for H.B. Fuller. H.B. Fuller's average media sentiment score of 0.88 beat Albemarle's score of -0.13 indicating that H.B. Fuller is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Albemarle
0 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
H.B. Fuller
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Albemarle presently has a consensus price target of $114.47, indicating a potential upside of 12.27%. H.B. Fuller has a consensus price target of $97.67, indicating a potential upside of 28.98%. Given H.B. Fuller's stronger consensus rating and higher possible upside, analysts plainly believe H.B. Fuller is more favorable than Albemarle.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Albemarle
1 Sell rating(s)
15 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.23
H.B. Fuller
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

92.9% of Albemarle shares are owned by institutional investors. Comparatively, 95.9% of H.B. Fuller shares are owned by institutional investors. 0.4% of Albemarle shares are owned by company insiders. Comparatively, 2.0% of H.B. Fuller shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

H.B. Fuller beats Albemarle on 11 of the 21 factors compared between the two stocks.

Get H.B. Fuller News Delivered to You Automatically

Sign up to receive the latest news and ratings for FUL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FUL vs. The Competition

MetricH.B. FullerAdhesives & sealants IndustryMaterials SectorNYSE Exchange
Market Cap$4.14B$3.67B$2.85B$19.85B
Dividend Yield1.17%0.70%5.26%3.50%
P/E Ratio23.3719.95119.0444.81
Price / Sales1.183.29578,814.7618.02
Price / Cash10.9227.5823.3921.68
Price / Book2.333.083.564.66
Net Income$144.91M$79.87M$147.51M$982.08M
7 Day Performance-3.71%-1.74%-4.10%-1.09%
1 Month Performance-4.85%-0.35%-3.73%1.37%
1 Year Performance-1.03%45.25%26.70%25.50%

H.B. Fuller Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FUL
H.B. Fuller
4.6197 of 5 stars
$75.72
-0.5%
$97.67
+29.0%
+5.1%$4.14B$3.51B23.377,200
ALB
Albemarle
3.7458 of 5 stars
$100.84
+0.9%
N/A-5.3%$11.85B$6.50B-6.029,000Analyst Forecast
Analyst Revision
CE
Celanese
4.9729 of 5 stars
$84.80
-5.5%
N/A-37.2%$10.10B$10.94B8.5312,410Analyst Downgrade
High Trading Volume
BCPC
Balchem
4.3834 of 5 stars
$179.32
+1.5%
N/A+49.5%$5.96B$922.44M48.201,302Positive News
NEU
NewMarket
2.1208 of 5 stars
$557.31
-0.3%
N/A+9.7%$5.35B$2.70B12.382,000Short Interest ↑
Positive News
ASH
Ashland
4.9208 of 5 stars
$80.96
+0.3%
N/A+5.9%$3.95B$2.11B24.173,800Short Interest ↓
SXT
Sensient Technologies
3.3392 of 5 stars
$79.57
-1.4%
N/A+37.6%$3.37B$1.53B38.073,956
IOSP
Innospec
3.9086 of 5 stars
$121.65
+1.4%
N/A+17.7%$3.03B$1.95B21.232,400Insider Selling
Short Interest ↓
Analyst Revision
High Trading Volume
KWR
Quaker Chemical
3.9034 of 5 stars
$169.95
+0.0%
N/A+3.6%$3.02B$1.86B24.924,400Positive News
MTX
Minerals Technologies
3.4354 of 5 stars
$82.49
+1.1%
N/A+36.1%$2.63B$2.12B17.484,070Positive News
SCL
Stepan
3.9938 of 5 stars
$79.05
-0.2%
N/A+1.4%$1.78B$2.33B39.332,389Short Interest ↑
Analyst Revision
News Coverage

Related Companies and Tools


This page (NYSE:FUL) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners